Demystifying Genetics in Hematologic Neoplasms
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: closed (25 July 2023) | Viewed by 1771
Special Issue Editor
Special Issue Information
Dear Colleagues,
Genetics in hematologic neoplasms is a complex yet important area. The advancement in next-generation sequencing techniques has fostered rapid development in both benign and malignant hematologic diseases. The use of high-throughput, single-cell DNA, RNA, and multi-omics analyses have provided an unprecedented opportunity to study and decipher the genotype and phenotype of hematologic neoplasms in high resolution. Many novel discoveries in genetics have revolutionized our understanding of the molecular basis of these diseases. The application of these findings has also significantly transformed the diagnosis, classification, risk stratification, treatment, and prognostication of nearly every form of hematologic neoplasms. Genetic tests have become an essential part of standard clinical practice during the diagnosis and treatment decision-making in most hematologic neoplasms.
This Special Issue aims to provide a platform for basic scientists and clinical investigators to exchange inspiring genetic discoveries by using cutting-edge techniques in the field of hematologic neoplasms. The studies on clinical and molecular correlation, genetics in clonal evolution, and drug-resistant mechanisms are especially welcome.
Dr. Ken-Hong Lim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematologic neoplasms
- genetics
- single-cell
- multi-omics
- next-generation sequencing
- clonal evolution
- drug resistance
